Eligo Bioscience receives EUR 2 Million from Seventure Partners to develop smart antibiotics


Eligo Bioscience, located at the Institut Pasteur in Paris, announced it received an investment of €2m in a seed round financing from Seventure Partners, one of Europe’s leaders in financing innovation and visionary investor in the microbiome field since 2008.

Back to top